13D Filing: Park West Asset Management and PLX Pharma Inc. (PLXP)

Page 7 of 10

Page 7 of 10 – SEC Filing

 

 

Item 5. Interest in Securities of the Issuer.
(a) – (e)

The aggregate percentage of Common Stock reported
owned by each person named herein is based upon 8,721,691 shares of Common Stock outstanding, which is the total number of shares
of Common Stock outstanding as of November 3, 2017 as reported in the Issuer’s quarterly report on Form 10-Q filed with the
Securities and Exchange Commission on November 9, 2017.

As of the date of the event which requires
the filing of this Schedule 13D (the “Event Date”), PWIMF held 953,465 shares of Common Stock and, subject to the limitation
described below, warrants to purchase up to 902,528 shares of Common Stock and PWPI held 122,258 shares of Common Stock and, subject
to the limitation described below, warrants to purchase up to 115,653 shares of Common Stock.  The warrants are not exercisable
until December 15, 2017, expire on June 14, 2027, and contain a provision prohibiting exercise to the extent that the holder, together
with its affiliates, would beneficially own in excess of 9.99% of the number of shares of Common Stock outstanding immediately
after giving effect to such exercise (subject to decrease upon prior written notice to the Issuer). As a result of the foregoing,
for purposes of Reg. Section 240.13d-3, PWAM and Mr. Park may be deemed to beneficially own the 1,075,723 shares of Common Stock
held in the aggregate by the PW Funds, and no shares of Common Stock underlying the warrants held in the aggregate by the PW Funds,
for an aggregate beneficial ownership percentage of approximately 12.3% of the shares of Common Stock deemed issued and outstanding
as of the Event Date; and PWIMF may be deemed to beneficially own 953,465 shares of Common Stock, and no shares of Common Stock
underlying its warrants, for an aggregate beneficial ownership percentage of approximately 10.9% of the shares of Common Stock
deemed issued and outstanding as of the Event Date.

Each of Mr. Park and PWAM has shared power
to vote or direct the vote of 1,075,723 shares of Common Stock.  Each of Mr. Park and PWAM has shared power to dispose
or direct the disposition of 1,075,723 shares of Common Stock.

PWIMF has shared power to vote or direct the
vote of 953,465 shares of Common Stock. PWIMF has shared power to dispose or direct the disposition of 953,465 shares of Common
Stock.

Each of PWAM and Mr. Park specifically disclaims
beneficial ownership in the shares of Common Stock reported herein except to the extent of their pecuniary interest therein.

 

 

Follow Plx Pharma Inc. (NASDAQ:PLXP)

Page 7 of 10